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http://dx.doi.org/10.1016/j.ajpath.2012.05.002CorrectionsIn the article entitled, “Toward Routine Use of 3D Histopa-
thology as a Research Tool” (Volume 180, pages 1835–1842
of the May 2012 issue of The American Journal of Pathology),
the support footnote should have included the following:
“This work was partially funded through WELMEC, a Centre
of Excellence in Medical Engineering funded by the Well-
come Trust and EPSRC (grant WT088908/Z/09/Z).”
In the April 2012 This Month in AJP feature (Volume
180, page 1333) highlighting “Amyloid Precursor Protein
Is a Biomarker for Transformed Human Pluripotent Stem
Cells,” the first author’s name was misspelled. The cor-
rect surname is Venkataramani.
In the article entitled, “ALDH1-Bright Epithelial Ovarian
Cancer Cells Are Associated with CD44 Expression,
Drug Resistance, and Poor Clinical Outcome” (Volume
180, pages 1159–1169 of the March 2012 issue), the
374location of the National Defense Medical Center was in-
correctly listed in the author affiliations and in the Ac-
knowledgments. The correct affiliation is National De-
fense Medical Center, Taipei, Taiwan.
In the article entitled, “Loss of Msx2 Function Down-
Regulates the FoxE3 Expression and Results in Ante-
rior Segment Dysgenesis Resembling Peters Anomaly”
(Volume 180, pages 2230-2239 of the June 2012 is-
sue), details for reprint requests were included, but the
corresponding author’s contact information was inad-
vertently omitted. Please address correspondence to
Jinsong Zhang, M.D., Eye Hospital of China Medical
University, Department of Ophthalmology, the 4th Af-
filiated Hospital of China Medical University, Provincial
Key Laboratory of Lens Research, Liaoning, China
110005. E-mail: cmu4h-zjs@126.com.
